DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,239,980 | +22.9% | 13,059 | +18.9% | 0.08% | +25.4% |
| Q2 2023 | $2,635,235 | -4.8% | 10,980 | -0.0% | 0.07% | -11.8% |
| Q1 2023 | $2,767,681 | -14.7% | 10,981 | -10.2% | 0.08% | -20.0% |
| Q4 2022 | $3,244,784 | -4.1% | 12,225 | -6.7% | 0.10% | -18.1% |
| Q3 2022 | $3,384,000 | +11.6% | 13,103 | +9.5% | 0.12% | +12.6% |
| Q2 2022 | $3,033,000 | -11.7% | 11,962 | +2.2% | 0.10% | 0.0% |
| Q1 2022 | $3,433,000 | -6.9% | 11,703 | +4.4% | 0.10% | -8.8% |
| Q4 2021 | $3,687,000 | +12.9% | 11,207 | +4.4% | 0.11% | 0.0% |
| Q3 2021 | $3,267,000 | +20.2% | 10,730 | +6.0% | 0.11% | +4.6% |
| Q2 2021 | $2,718,000 | +27.2% | 10,127 | +6.7% | 0.11% | +14.9% |
| Q1 2021 | $2,136,000 | +7.1% | 9,492 | +5.8% | 0.09% | 0.0% |
| Q4 2020 | $1,994,000 | -6.9% | 8,974 | -9.8% | 0.09% | -18.3% |
| Q3 2020 | $2,141,000 | +24.2% | 9,944 | +2.0% | 0.12% | +10.6% |
| Q2 2020 | $1,724,000 | +36.1% | 9,752 | +6.6% | 0.10% | -4.6% |
| Q1 2020 | $1,267,000 | +19.3% | 9,151 | +32.3% | 0.11% | +39.7% |
| Q4 2019 | $1,062,000 | +8.4% | 6,918 | +2.0% | 0.08% | -3.7% |
| Q3 2019 | $980,000 | +6.6% | 6,785 | +5.5% | 0.08% | +2.5% |
| Q2 2019 | $919,000 | +1.3% | 6,431 | -6.3% | 0.08% | +2.6% |
| Q1 2019 | $907,000 | +48.9% | 6,867 | +16.2% | 0.08% | +35.1% |
| Q4 2018 | $609,000 | -8.4% | 5,908 | -3.5% | 0.06% | -16.2% |
| Q3 2018 | $665,000 | +27.4% | 6,124 | +15.7% | 0.07% | +17.2% |
| Q2 2018 | $522,000 | +14.5% | 5,294 | +13.8% | 0.06% | +9.4% |
| Q1 2018 | $456,000 | +48.5% | 4,653 | +40.8% | 0.05% | +43.2% |
| Q4 2017 | $307,000 | +40.2% | 3,304 | +29.3% | 0.04% | +27.6% |
| Q3 2017 | $219,000 | +1.4% | 2,555 | -0.2% | 0.03% | -6.5% |
| Q2 2017 | $216,000 | -8.1% | 2,560 | -6.9% | 0.03% | -11.4% |
| Q1 2017 | $235,000 | +16.3% | 2,751 | +6.8% | 0.04% | +16.7% |
| Q3 2016 | $202,000 | -9.8% | 2,576 | +16.4% | 0.03% | -9.1% |
| Q2 2016 | $224,000 | +14.9% | 2,213 | +7.7% | 0.03% | 0.0% |
| Q1 2016 | $195,000 | +14.0% | 2,054 | +11.5% | 0.03% | 0.0% |
| Q4 2015 | $171,000 | +11.8% | 1,842 | +2.8% | 0.03% | -5.7% |
| Q3 2015 | $153,000 | +11.7% | 1,791 | +12.1% | 0.04% | +16.7% |
| Q2 2015 | $137,000 | -1.4% | 1,598 | -2.2% | 0.03% | -11.8% |
| Q1 2015 | $139,000 | -31.9% | 1,634 | -31.5% | 0.03% | -33.3% |
| Q4 2014 | $204,000 | +71.4% | 2,384 | +52.7% | 0.05% | +30.8% |
| Q3 2014 | $119,000 | -3.3% | 1,561 | 0.0% | 0.04% | -9.3% |
| Q2 2014 | $123,000 | -10.9% | 1,561 | -15.0% | 0.04% | -23.2% |
| Q1 2014 | $138,000 | -4.2% | 1,836 | -1.8% | 0.06% | +7.7% |
| Q4 2013 | $144,000 | -16.8% | 1,870 | -25.2% | 0.05% | -29.7% |
| Q3 2013 | $173,000 | +22.7% | 2,499 | +12.4% | 0.07% | +1.4% |
| Q2 2013 | $141,000 | – | 2,224 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |